We asked three of the top U.S. HIV clinicians to give us their take on some of the most critical issues in HIV, including:
Listen to each podcast to hear what these experts had to say. (Transcripts for each podcast are also available.)
Calvin J. Cohen, M.D., M.S., Community Research Initiative of New England and Harvard Medical School, Boston, Mass. Listen Read interview |
Eric Daar, M.D., Harbor-UCLA Medical Center in Los Angeles, Calif. Listen Read interview |
Benjamin Young, M.D., Ph.D., Denver ID Consultants, Rose Medical Center, Denver, Colo. Listen Read interview |
Additional Podcasts | |
![]() Robin Isaacs, M.D., Merck & Co., Inc. We also had the opportunity to talk to Robin Isaacs, M.D., executive director of infectious disease and HIV vaccine research at Merck. He spoke about the MK-0518 data presented at ICAAC 2006. This new integrase inhibitor has shown impressive results both in treatment-experienced and treatment-naive HIV-infected patients. Listen Read interview |
![]() Gregory Smiley, American Academy of HIV Medicine, Washington, DC Gregory Smiley is Director of Public Policy and Government Relations at the American Academy of HIV Medicine, an organization of 2,000 HIV specialists providing care to more than 340,000 people with HIV. Smiley discusses why the Ryan White CARE Act is an "anchor of [HIV] care" for HIV-infected people in the United States, and offers his view on why the U.S. Congress has taken so long to reauthorize it. Listen Read interview |
Copyright © 2007 Body Health Resources Corporation. All rights reserved. Podcast disclaimer
This article was provided by The Body PRO. Copyright © Body Health Resources Corporation. All rights reserved.
| Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here. |